ArticleEvidence-based complementary and alternative medicine : eCAM2022

Evaluation of a Dual PI3K/mTOR Inhibitor PF-04691502 against Bladder Cancer Cells.

Xiaosong Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.